Sphere Health expands its clinical offerings with a new program focused on hormonal and metabolic health, addressing conditions ranging from PMOS to menopause.
The company announced the launch of a new women's hormonal health care program, which is a positive product expansion but lacks specific financial details or market-moving guidance.
Sphere Health has introduced a specialized care program targeting hormonal and metabolic health, including conditions like polyendocrine metabolic ovarian syndrome. The initiative aims to address the underlying factors of women's well-being from perimenopause through menopause.
The program focuses on the hormonal and metabolic health of women, specifically targeting conditions such as perimenopause, menopause, and polyendocrine metabolic ovarian syndrome.